Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TIPARP | Q7Z3E1 | 19/20 | 0.44 |
| ▸ | PARP2 | Q9UGN5 | 4/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | PARP12 | Q9H0J9 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24640451 | 1.00 | TIPARP (0.44) | TIPARPPARP2PARP1CYP2C9CYP2C19 | |
| SCHEMBL24640452 | 1.00 | TIPARP (0.44) | TIPARPPARP2PARP1CYP2C9CYP2C19 | |
| SCHEMBL24640462 | 0.86 | MDM2 (0.42) | TIPARPCYP2C9CYP2C19MDM2 | |
| SCHEMBL24640469 | 0.86 | KDM5C (0.36) | TIPARPPARP2PARP1CYP2C9CYP2C19 | |
| SCHEMBL24640471 | 0.86 | KDM5C (0.36) | TIPARPPARP2PARP1CYP2C9CYP2C19 | |
| SCHEMBL24640470 | 0.86 | KDM5C (0.36) | TIPARPPARP2PARP1CYP2C9CYP2C19 | |
| SCHEMBL24640467 | 0.86 | MDM2 (0.42) | TIPARPCYP2C9CYP2C19MDM2 | |
| SCHEMBL24640453 | 0.86 | MDM2 (0.42) | TIPARPCYP2C9CYP2C19MDM2 | |
| SCHEMBL24639515 | 0.83 | TEAD1 (0.40) | TIPARPPARP2CYP2C9MDM2 | |
| SCHEMBL24639542 | 0.83 | TEAD1 (0.40) | TIPARPPARP2CYP2C9MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022170974-A1 | TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-08-18 | — | — | WO | disclosed |